首页> 外文期刊>Biomaterials >Indomethacin-loaded methoxy poly(ethylene glycol)/ poly(epsilon-caprolactone) diblock copolymeric nanosphere: pharmacokinetic characteristics of indomethacin in the normal Sprague-Dawley rats.
【24h】

Indomethacin-loaded methoxy poly(ethylene glycol)/ poly(epsilon-caprolactone) diblock copolymeric nanosphere: pharmacokinetic characteristics of indomethacin in the normal Sprague-Dawley rats.

机译:吲哚美辛负载的甲氧基聚(乙二醇)/聚(ε-己内酯)二嵌段共聚物纳米球:吲哚美辛在正常Sprague-Dawley大鼠中的药代动力学特征。

获取原文
获取原文并翻译 | 示例
           

摘要

We prepared the drug-loaded polymeric nanospheres composed of the methoxy poly(ethylene glycol) (MePEG) and poly(epsilon-caprolactone) (PCL) that showed a narrow size distribution and average diameter of less than 200 nm. We could obtain the nanosphere having a relatively high drug-loading efficiency of about 42% when the feed weight ratio of indomethacin (IMC) to polymer was 1:1. To investigate the IMC pharmacokinetics in the IMC-loaded MePEG/PCL nanosphere (DMEP70) using the rats as animal model, we analyzed the IMC concentration in plasma with HPLC after i.v. bolus administered at a dose of 10 mg/kg in free IMC (control) and IMC-loaded MePEG/PCL nanosphere (DMEP70) groups via tail vein. Pharmacokinetics parameters (mean +/- s.d.) such as the mean residence time (MRT, h), the steady-state volume of distribution (Vdss, l), the terminal half-time (t 1/2, h) and the plasma clearance (CL, l/h) of IMC in each groups (control vs. DMEP70) were determined; MRT (16.97 +/- 4.83 vs. 28.69 +/- 11.28, p < 0.01); Vdss (14.26 +/- 4.86 vs. 20.37 +/- 12.04, p < 0.05); t 1/2 (15.12 +/- 4.77 vs. 23.1 +/- 8.24, p < 0.01); CL (0.84 +/- 0.27 vs. 0.71 +/- 0.41). From these results, we could concluded that MEP70 has a significant potential for sustained release and the enhancement of circulation time of loaded drug by prolonging terminal half-life, increasing MRT and Vdss of IMC. Therefore, The MePEG/PCL block copolymeric nanosphere system is being considered as promising biodegradable and biocompatible drug carrier vehicles for parentral use and may be useful as sustained release injectable delivery systems for hydrophobic drugs.
机译:我们制备了由甲氧基聚(乙二醇)(MePEG)和聚(ε-己内酯)(PCL)组成的载有药物的聚合物纳米球,其显示出狭窄的尺寸分布且平均直径小于200 nm。当吲哚美辛(IMC)与聚合物的进料重量比为1:1时,我们可以获得具有约42%的较高载药效率的纳米球。为了使用大鼠作为动物模型研究在IMC负载的MePEG / PCL纳米球(DMEP70)中的IMC药代动力学,我们在静脉内注射后用HPLC分析了血浆中IMC的浓度。通过尾静脉以10 mg / kg的剂量在游离IMC(对照组)和IMC负载的MePEG / PCL纳米球(DMEP70)组中快速推注。药代动力学参数(平均+/- sd),例如平均停留时间(MRT,h),稳态分布体积(Vdss,l),终末半衰期(t 1/2,h)和血浆确定每组中IMC的清除率(CL,l / h)(对照vs. DMEP70);捷运(16.97 +/- 4.83与28.69 +/- 11.28,p <0.01); Vdss(14.26 +/- 4.86与20.37 +/- 12.04,p <0.05); t 1/2(15.12 +/- 4.77与23.1 +/- 8.24,p <0.01); CL(0.84 +/- 0.27与0.71 +/- 0.41)。从这些结果,我们可以得出结论,MEP70具有延长释放半衰期,增加IMC的MRT和Vdss的显着潜力,可以持续释放并延长载药的循环时间。因此,MePEG / PCL嵌段共聚物纳米球系统被认为是有希望用于肠胃外用途的可生物降解和生物相容性药物载体,并且可用作疏水药物的缓释注射给药系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号